Niagen Bioscience (NAGE) Interest Coverage Ratio Growth (3y) (2014 - 2022)
Niagen Bioscience (NAGE) Interest Coverage Ratio Growth (3y) (2014 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Niagen Bioscience |
280.11 Mn |
213.56 Mn |
19.98 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2022 |
-203.46% |
| Jun 30, 2022 |
-271.20% |
| Sep 30, 2021 |
14.86% |
| Jun 30, 2021 |
-55.92% |
| Mar 31, 2021 |
-26.62% |
| Dec 31, 2020 |
-23.97% |
| Sep 30, 2020 |
-46.26% |
| Jun 30, 2020 |
-27.79% |
| Sep 30, 2019 |
62.29% |
| Jun 30, 2019 |
-137.43% |
| Sep 30, 2018 |
-894.10% |
| Jun 30, 2018 |
-343.82% |
| Sep 30, 2017 |
-10.71% |
| Jul 1, 2017 |
18.62% |
| Apr 2, 2016 |
26.01% |
| Jan 2, 2016 |
-27.47% |
| Oct 3, 2015 |
26.08% |
| Jul 4, 2015 |
86.16% |
| Sep 27, 2014 |
45.36% |
| Jun 28, 2014 |
15.14% |
